Abbott | Le Bénéfice D'Exploitation

Prix De L'Action
114.73
Variation Quotidienne
0.15 0.13%
Mensuellement
5.48%
Annuel
-15.61%
Q1 Prévisions
108.73




Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
Agilent USD 443M 66M 2025-09
AtriCure USD 2.49M 2.28M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 140.4M 35.3M 2025-09
Danaher USD 1.5B 348M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Hologic USD 237M 16M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 11.76M 13.07M 2025-09
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 5.59B 1.81B 2025-12
Masimo USD 83.6M 19.1M 2025-09
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Smith & Nephew USD 440M 50M 2025-12
Solventum Corp USD 1.69B 1.47B 2025-09
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD -408.9M 586.38M 2025-09
Terumo JPY 43.88B 1.21B 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12


Abbott Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.